Culley Brian M
SEC CIK 1310683 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | Pres, CEO, Dir | 255.5K | $76.0K | — | 23 | 2021-09-30 | 2026-03-12 |
Most active insiders at LCTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Culley Brian M | Pres, CEO, Dir | $24.4K | — |
| 2 | Samuel George A. III | GC, Sec | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-12 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.63 | +15.0K | 255.5K | +6% | +$24.4K | |
| D | 2026-02-13 | 2026-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 253.4K | +14% | — |
| D | 2026-02-13 | 2026-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.80 | -12.9K | 240.5K | -5% | -$23.2K |
| 2025-12-19 | 2025-12-19 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | A - Grant | — | +8,925 | 222.5K | +4% | — | |
| 2025-12-19 | 2025-12-19 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.68 | -334 | 222.1K | -0.2% | -$561.12 | |
| D | 2025-02-12 | 2025-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 226.1K | +16% | — |
| D | 2025-02-12 | 2025-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $0.65 | -12.5K | 213.5K | -6% | -$8,156 |
| 2024-11-22 | 2024-11-21 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | P - Purchase | $0.6 | +40.0K | 194.8K | +26% | +$24.0K | |
| 2024-05-28 | 2024-05-24 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.05 | +10.0K | 154.8K | +7% | +$10.5K | |
| D | 2024-02-12 | 2024-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 157.6K | +25% | — |
| D | 2024-02-12 | 2024-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.08 | -12.8K | 144.8K | -8% | -$13.8K |
| D | 2023-02-14 | 2023-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 139.1K | +29% | — |
| D | 2023-02-14 | 2023-02-11 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.35 | -12.7K | 126.4K | -9% | -$17.2K |
| D | 2022-06-30 | 2022-06-30 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 113.2K | +16% | — |
| D | 2022-06-30 | 2022-06-30 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.58 | -5,343 | 107.9K | -5% | -$8,442 |
| D | 2022-04-04 | 2022-03-31 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.53 | +6,400 | 97.8K | +7% | +$9,792 |
| D | 2022-04-04 | 2022-03-31 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.54 | -5,343 | 91.4K | -6% | -$8,228 |
| D | 2022-04-04 | 2022-03-31 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 96.7K | +19% | — |
| 2022-03-28 | 2022-03-25 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.38 | +5,250 | 81.3K | +7% | +$7,245 | |
| D | 2022-01-03 | 2021-12-31 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 81.4K | +23% | — |
| D | 2022-01-03 | 2021-12-31 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $2.45 | -5,343 | 76.0K | -7% | -$13.1K |
| D | 2021-10-12 | 2021-09-30 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | F - Tax | $2.52 | -5,343 | 65.9K | -7% | -$13.5K |
| D | 2021-10-12 | 2021-09-30 | LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 71.3K | +28% | — |
Purchase Sale Sale after option exercise All abbreviations